SETTING: Following a large-scale contact investigation, individuals with a positive tuberculin skin test (TST) result were offered preventive tuberculosis treatment. OBJECTIVE: To investigate the effect of isoniazid (INH) treatment and the effect of time on interferon gamma release assay (IGRA) results during follow-up. DESIGN: TST-positive subjects (n = 122) detected during the large-scale contact investigation were included in the study. Blood was obtained every 6 months over 2 years to perform both tests. RESULTS: Preventive INH treatment was completed by 36 of the 122 (29.5%) subjects, 71 (58.2%) were followed up with 6-monthly X-ray screening and 15 (12.3%) did not complete INH treatment. The overall percentage of individuals with a positive result remained stable during the 2 years, at approximately 45-50%, but individual responses varied over time. The majority of initially low IGRA results remained below the cut-off value, initially high IGRA results remained positive, while initially intermediate IGRA results were followed by more dynamic patterns. CONCLUSION: This study showed a highly variable pattern of IGRA responses over time and suggests limited value for their use during follow-up of latently infected individuals. However, the significance of different kinetic patterns observed among subjects with intermediate initial IGRA results warrants further study.
SETTING: Following a large-scale contact investigation, individuals with a positive tuberculin skin test (TST) result were offered preventive tuberculosis treatment. OBJECTIVE: To investigate the effect of isoniazid (INH) treatment and the effect of time on interferon gamma release assay (IGRA) results during follow-up. DESIGN: TST-positive subjects (n = 122) detected during the large-scale contact investigation were included in the study. Blood was obtained every 6 months over 2 years to perform both tests. RESULTS: Preventive INH treatment was completed by 36 of the 122 (29.5%) subjects, 71 (58.2%) were followed up with 6-monthly X-ray screening and 15 (12.3%) did not complete INH treatment. The overall percentage of individuals with a positive result remained stable during the 2 years, at approximately 45-50%, but individual responses varied over time. The majority of initially low IGRA results remained below the cut-off value, initially high IGRA results remained positive, while initially intermediate IGRA results were followed by more dynamic patterns. CONCLUSION: This study showed a highly variable pattern of IGRA responses over time and suggests limited value for their use during follow-up of latently infected individuals. However, the significance of different kinetic patterns observed among subjects with intermediate initial IGRA results warrants further study.
Authors: Christian Lienhardt; Katherine Fielding; Abdoul A Hane; Aliou Niang; Cheikh T Ndao; Farba Karam; Helen Fletcher; Fatou Mbow; Jules-François Gomis; Raymond Diadhiou; Roger Diadhiou; Maxime Toupane; Tandakha Dieye; Souleymane Mboup Journal: PLoS One Date: 2010-05-06 Impact factor: 3.240
Authors: Felix C Ringshausen; Albert Nienhaus; Anja Schablon; Stephan Schlösser; Gerhard Schultze-Werninghaus; Gernot Rohde Journal: BMC Infect Dis Date: 2010-07-23 Impact factor: 3.090
Authors: Simone A Joosten; Krista E van Meijgaarden; Sandra M Arend; Corine Prins; Fredrik Oftung; Gro Ellen Korsvold; Sandra V Kik; Rob Jw Arts; Reinout van Crevel; Mihai G Netea; Tom Hm Ottenhoff Journal: J Clin Invest Date: 2018-04-03 Impact factor: 14.808
Authors: Grant Theron; Jonny Peter; Laura Lenders; Richard van Zyl-Smit; Richard Meldau; Ureshnie Govender; Keertan Dheda Journal: PLoS One Date: 2012-05-22 Impact factor: 3.240
Authors: Matthew K O'Shea; Thomas E Fletcher; Nicholas J Beeching; Martin Dedicoat; David Spence; Helen McShane; Adam F Cunningham; Duncan Wilson Journal: PLoS One Date: 2014-05-09 Impact factor: 3.240
Authors: Synne Jenum; Harleen M S Grewal; David A Hokey; John Kenneth; Mario Vaz; Timothy Mark Doherty; Frode Lars Jahnsen Journal: PLoS One Date: 2014-07-03 Impact factor: 3.240
Authors: A Bedini; E Garlassi; C Stentarelli; S Petrella; M Meacci; B Meccugni; M Meschiari; E Franceschini; S Cerri; A Brasacchio; F Rumpianesi; L Richeldi; C Mussini Journal: New Microbes New Infect Date: 2016-04-07